In continuation to its intimation dated September 06, 2024, wherein the company had informed that the Company will file an application to the office of the Registrar of Companies, Bangalore, Karnataka, seeking an extension of time by three months for the convening of Annual General Meeting ('AGM') for the Financial Year 2023-24. Vivimed Labs has informed that Registrar of Companies, Bangalore, Karnataka vide its approval letter dated October 07, 2024, has accorded its approval to the Company under Section 96 of the Companies Act, 2013 allowing the Company to conduct its Annual General Meeting for the financial year ended on March 31, 2024 on or before November 14, 2024 i.e an extension of 01 month 15 days (45 days) to hold the Annual General Meeting. In view of the above-mentioned approval dated October 07, 2024 by the Registrar of Companies, Bangalore, Karnataka, the Company shall convene its AGM for the Financial Year 2023-24 within such extended timeline and the date of AGM shall be intimated in due course of time, upon approval of the Board.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |